# Biomat USA Inc – FDA Inspection, Mar 14, 2019

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/c4914351-cfb9-405c-a6b8-44b454c1c888
Source feed: FDA_Inspections

> FDA inspection 1082533 of Biomat USA Inc, March 14, 2019. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1082533
- Company Name: Biomat USA Inc
- Inspection Date: 2019-03-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1002170 - 2017-02-15
- [FDA Inspection 925809 - 2015-05-08](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/d7042f07-db5e-4b3f-a2b0-7d099e6b1721)
- FDA Inspection 812446 - 2012-12-20
- FDA Inspection 563661 - 2009-01-28

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/christopher-j-adams/f7010846-7fd1-4ee8-901a-1015656fea0a)

Company: https://www.keypedia.com/companies/biomat-usa-inc/98944397-cd4f-40dc-bcd7-f0a62b2a7cc3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
